Patent · US Active

Liposome composition

US12042560B2 · kind B2 · utility

0Cited by
24References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 23, 2013
Grant dateJul 23, 2024
Priority date
Expiry dateOct 23, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a novel liposome composition containing eribulin or its pharmacologically permissible salt, and its method of manufacture.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.